Cancer
MIT chemists have developed a new targeted cancer therapy using tiny particles called nanoparticles that can deliver a large range of chemotherapy drugs directly to tumor cells. The new therapy, which is guided by antibodies that target specific tumor proteins, uses bottlebrush-shaped polymer chains carrying dozens or hundreds of drug
Cancer
US Senators Elissa Slotkin (D-MI) and Susan Collins (R-ME) have re-introduced the bipartisan Federal Firefighter Cancer Detection and Prevention Act, legislation that would provide no-cost cancer screenings to federal firefighters employed by the Department of Defense. This move aims to address the unique risks faced by firefighters, including frequent exposure
Cancer
Researchers from First Hospital of China Medical University have made a significant breakthrough in the treatment of gastrointestinal tumors. According to a study published in Frontiers in Medicine, the combination of nanotechnology and natural killer (NK) cell immunotherapy has shown promise in targeting cancer cells while minimizing harm to healthy
Cancer
As the nation's fire departments continue to respond to emergency situations, federal firefighters remain at risk of developing cancer due to their occupational exposures to toxic substances like PFAS chemicals. In a bid to address this critical issue, U.S. Senators Susan Collins and Elissa Slotkin have introduced
Cancer
Researchers from King Abdulaziz City for Science and Technology (KACST) have made a breakthrough in cancer gene therapy by exploring unconventional immunotherapy platforms. These novel approaches leverage diverse immune cell subsets and synthetic biologics to overcome the limitations of traditional immunotherapies. According to the study, unconventional immunotherapies have the potential
Cancer
Researchers at Kobe Pharmaceutical University have made a significant discovery in the field of cancer gene therapy, using mesenchymal stem cells (MSCs) to target solid tumors. In a new report, the team revealed that MSCs can be used as biomimetic carriers for active drug delivery systems, loading liposomes onto their
Cancer
Research from King Abdulaziz City for Science and Technology (KACST) has shed light on the potential of cancer gene therapy with the introduction of innovative nanoparticle-based approaches. This new paradigm shift in cancer treatment leverages the host's immune system to combat established tumors, but existing methods have limitations,
Cancer
Charity ambassadors and cyclists, Harry and Charlie Tanfield, are undertaking a challenging two-day, 400km (250-mile) journey from Harrogate to Westminster, carrying hundreds of white roses to push for better cancer care in Yorkshire. The brothers, who have previously supported Yorkshire Cancer Research, aim to raise awareness and funds for the
Cancer
The World Health Organization (WHO) has published updated editions of its Model List of Essential Medicines (EML) and Essential Medicines for Children (EMLc) to include new treatments for several cancers and for diabetes and related conditions such as obesity. The updated lists highlight medicines that address priority health needs worldwide
Cancer
Researchers from the Second Military Medical University in Shanghai, People's Republic of China, have made significant progress in the development of a novel treatment for advanced gastric cancer. The study, published in the Journal of Molecular Therapy, explores the effectiveness of IMC001, an autologous EpCAM-targeted CAR-T cell therapy,
Cancer
CERo Therapeutics Holdings, Inc. has announced the receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for its Application 19/019,111, in addition to a patent granted in Japan, further solidifying its intellectual property portfolio. These developments bring the total number of granted patents
Cancer
A major new research project, led by UCLA and UC Davis, in collaboration with CAL FIRE, will investigate how occupational exposures among California firefighters may increase cancer risk. The project, a sub-study of the California Firefighter Cancer Research Study (CAFF-CRS), is backed by nearly $9.7 million in funding from
